A large case-control study using genetic proxies for PCSK9 inhibitors may help alleviate concerns that the dyslipidemia agents could promote adverse cardiac remodeling and heart failure.
Denmark: A recent study, published in the Journal of the American Heart Association found that HMG-CoA reductase inhibition (the target of statins) is associated with a high risk of cataract.
According to the findings of a recent study, individuals with genetic variations linked to statin medications appear to have an increased risk of developing cataracts and having cataract surgery.
Cholesterol-lowering gene changes may increase risk of cataracts miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.